| Michelle Hobson, | |
|
2 Corporate Plaza Dr, Newport Beach, CA 92660-7929 | |
| (949) 386-2656 | |
| Not Available |
| Full Name | Michelle Hobson |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 2 Corporate Plaza Dr, Newport Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003327396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 102420 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Hobson, 20452 Bayview Ave, Newport Beach, CA 92660-0710 Ph: (949) 433-9944 | Michelle Hobson, 2 Corporate Plaza Dr, Newport Beach, CA 92660-7929 Ph: (949) 386-2656 |
News Archive
Pediatrics, the journal of the American Academy of Pediatrics, today published a paper from The Lullaby Trust and partner international organizations, which sets out new global priorities for tackling Sudden Unexpected Death in Infancy (SUDI).
People who inject drugs (PWID) can significantly reduce their risk of HIV infection with the use of opiate substitution treatments such as methadone, as suggested by an international team of researchers in a paper published today on bmj.com.
NewCardio, Inc., a cardiac diagnostic technology provider, announced today that on January 12, 2010, it received notice of allowance for U.S. patent 7,647,093, titled "Apparatus and method for cordless recording and telecommunication transmission of three special ECG leads and their processing," from the U.S. Patent and Trademark Office.
​Within two years of implementation, Blue Cross Blue Shield of Massachusetts' Alternative Quality Contract (AQC) had a small but significant positive effect on the quality of pediatric care, according to a new study from Boston Children's Hospital. The results were published online Dec. 23 in Pediatrics.
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
› Verified 6 days ago
Leilani Jane Carinio, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1151 Dove St Ste 245, Newport Beach, CA 92660 Phone: 714-585-9447 | |
Ms. Jacqueline Islas, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1151 Dove St Ste 140, Newport Beach, CA 92660 Phone: 949-630-5006 | |
Rosemarie Dahlstrom, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1000 Quail St Ste 155, Newport Beach, CA 92660 Phone: 949-777-6694 | |
Mrs. Joanne Meyerson, MARRIAGE AND FAMILY Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1400 Quail Street, # 235, Newport Beach, CA 92660 Phone: 949-559-6600 Fax: 949-559-4909 | |
Dr. Jennifer Amanda Flowers, PSY. D., MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1000 Quail St Ste 275, Newport Beach, CA 92660 Phone: 949-863-9031 Fax: 949-863-3132 | |
Czarina Pangilinan De Jesus, AMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 26 Corporate Plaza Dr Ste 280, Newport Beach, CA 92660 Phone: 562-553-2403 |